Croda completes acquisition of Solus Biotech

Regulatory News Release

4 July 2023

Croda successfully completes acquisition of Solus Biotech

Croda International Plc ('Croda') today confirms that, following receipt of unconditional approval from the South Korean regulatory authorities, it has now successfully completed the acquisition of Solus Biotech, a global leader in premium, biotechnology-derived active ingredients for beauty care and pharmaceuticals.

This follows the announcement on 6 February 2023 that Croda had reached an agreement to acquire Solus Biotech.

-ENDS-

Further information:

Investors: David Bishop, Croda                                              +44 7823 874428

Media: Charlie Armitstead, Teneo                                          +44 7703 330269

About Croda:

Croda is the company that uses smart science to create high performance ingredients and technologies that improve lives. For more information see: www.croda.com.